Lexatumumab (TRAIL-receptor 2 mAb) induces expression of...

Lexatumumab (TRAIL-receptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic model

Liang Zhang, Xiaoping Zhang, Glen W. Barrisford, Aria F. Olumi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
251
Year:
2007
Language:
english
Pages:
158
DOI:
10.1016/j.canlet.2006.11.013
File:
PDF, 2.14 MB
english, 2007
Conversion to is in progress
Conversion to is failed